LRT Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-931
Closed -$326K 102
2025
Q4
$326K Buy
+931
New +$315K 0.28% 77
2023
Q4
Sell
-3,665
Closed -$1.6M 90
2023
Q3
$1.6M Buy
3,665
+80
+2% +$36.3K 1.11% 38
2023
Q2
$1.58M Buy
3,585
+2,385
+199% +$1.1M 1.16% 41
2023
Q1
$552K Buy
+1,200
New +$571K 0.41% 63

Other funds holding ELV

LRT Capital Management's ELV Position: Q1 2026 in Review

LRT Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 931 shares — an estimated $326K sold.

LRT Capital Management first reported a position in ELV in Q1 2023 and held it in 4 quarters. The position peaked at $1.6M in Q3 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • LRT Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • LRT Capital Management sold 931 Elevance Health shares in Q1 2026, an estimated $326K.
  • LRT Capital Management first reported a position in Elevance Health in Q1 2023 and held it in 4 quarters.
  • LRT Capital Management's Elevance Health position peaked at $1.6M in Q3 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on LRT Capital Management's 13F filing for Q1 2026, filed 15 May 2026.